Today: 2 May 2026
Chevron stock ticks higher as Tengiz restarts and Iran shipping warning lifts oil
9 February 2026
1 min read

Chevron stock ticks higher as Tengiz restarts and Iran shipping warning lifts oil

New York, February 9, 2026, 13:54 EST — Regular session

  • Chevron shares picked up roughly 0.7% in afternoon trading, moving alongside stronger crude.
  • Chevron’s Tengiz field output is reportedly back up to about 60%, with full production eyed by Feb. 23.
  • Oil climbed over 1% following a U.S. advisory to ships operating near Iran.

Chevron shares ticked higher Monday, buoyed by rising oil prices and indications that production is picking back up at a key Kazakhstan field it runs.

This is significant for Chevron, whose cash flow in the short run remains highly sensitive to swings in crude prices. Traders haven’t hesitated to mark up or down energy shares when new risks to supply surface. That “risk premium” in oil—the markup traders tack on to account for possible disruption—has started creeping back in.

Physical flows could pick up in the next few weeks if the massive Tengiz oilfield comes back online, though right now, the price moves have more to do with geopolitics than with any barrels from Kazakhstan.

Chevron traded 0.7% higher at $182.19. Exxon Mobil picked up around 0.7% as well. Shell’s U.S.-listed shares climbed close to 3%.

Production at Kazakhstan’s Chevron-operated Tengiz field is back up to about 60% of its peak, according to two people in the industry, following last month’s fires that hit power infrastructure. As of Feb. 8, the sources estimated output near 550,000 barrels a day. The goal: restore the flow to approximately 950,000 bpd by Feb. 23.

Crude jumped over 1% after the U.S. Department of Transportation told U.S.-flagged ships to steer well clear of Iranian waters when passing through the Strait of Hormuz and Gulf of Oman. Brent gained 1.3%, trading near $68.94 a barrel. U.S. WTI matched that move, up 1.3% to approximately $64.38. About 20% of the world’s oil runs through the Hormuz chokepoint. “The Iranian risk premium cannot be fully defused,” SEB’s Bjarne Schieldrop said. UBS analyst Giovanni Staunovo called the setup “extremely difficult to judge,” with traders focused on when fresh talks might take place. Reuters

Chevron’s Tengiz operation shows how even with crude propping up the stock, a snag on the ground can dent volumes. The consortium runs the field, and the market usually folds fresh headlines into the larger supply narrative.

Still, those tailwinds aren’t guaranteed to last. A de-escalation in the Gulf or renewed attention on expanding supply — especially if Tengiz ramps up sooner than forecast — could knock oil lower and drag energy stocks alongside.

Investors are eyeing any fresh news on shipping and diplomatic moves involving Iran. Attention also stays fixed on whether Tengiz sticks to its Feb. 23 target for restoring full output.

Stock Market Today

  • Chugai Pharmaceutical Reports Strong Q1 Earnings, Introduces Trust-Based Stock Plan
    May 2, 2026, 1:28 AM EDT. Chugai Pharmaceutical (TSE:4519) posted robust first-quarter 2026 earnings, with sales of ¥291.6 billion, revenue of ¥321.7 billion, and net income of ¥115.4 billion surpassing prior year levels. The company's board unveiled a trust-based stock compensation system to better align management incentives with performance amid rising R&D expenses and strategic collaborations. Despite near-term strength, investors face risks from patent expiries, biosimilars, and National Health Insurance (NHI) price revisions that could pressure margins. Forecasts project ¥1.38 trillion revenue and ¥517 billion earnings by 2028, implying modest growth. Analysts remain divided, with some optimistic on AI-driven pipeline advancements, while others caution on pricing and competitive threats. The governance changes highlight an evolving incentive model as Chugai navigates opportunities and challenges in biologics and Roche partnership dynamics.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 02.05.2026

2 May 2026
LIVEMarkets rolling coverageStarted: May 2, 2026, 12:00 AM EDTUpdated: May 2, 2026, 1:43 AM EDT Chugai Pharmaceutical Reports Strong Q1 Earnings, Introduces Trust-Based Stock Plan May 2, 2026, 1:28 AM EDT. Chugai Pharmaceutical (TSE:4519) posted robust first-quarter 2026 earnings, with sales of ¥291.6 billion, revenue of ¥321.7 billion, and net income of ¥115.4 billion surpassing prior year levels. The company's board unveiled a trust-based stock compensation system to better align management incentives with performance amid rising R&D expenses and strategic collaborations. Despite near-term strength, investors face risks from patent expiries, biosimilars, and National Health Insurance (NHI) price revisions that could
US Stock Market Today After Hours: Nasdaq Tops 25,000 As S&P 500 Hits Record High

US Stock Market Today After Hours: Nasdaq Tops 25,000 As S&P 500 Hits Record High

2 May 2026
Nasdaq 100 futures climbed 0.68% and S&P 500 futures edged up 0.06% in early after-hours trading Friday, while Dow futures slipped 0.48%. The S&P 500 and Nasdaq closed at record highs, driven by first-quarter S&P 500 profit growth of 27.8%, according to LSEG. Oil prices, inflation signals, and upcoming jobs data remain in focus. GameStop shares rose 4% after reports it was preparing an offer for eBay.
McDonald’s Corporation Stock Slides Before Earnings as Its Big Drink Bet Comes Due

McDonald’s Corporation Stock Slides Before Earnings as Its Big Drink Bet Comes Due

2 May 2026
McDonald’s shares fell 2.37% to $286.64 on Friday, underperforming rivals ahead of its May 7 earnings report and a U.S. launch of six new McCafé specialty drinks. The company will begin selling the drinks nationwide on May 6, adding beverage specialist roles at 14,000 restaurants. Investors are watching whether the new drinks and value offers can boost traffic without slowing service or hurting margins.
CrowdStrike stock jumps as software rebounds — what to watch next for CRWD
Previous Story

CrowdStrike stock jumps as software rebounds — what to watch next for CRWD

Kyndryl stock plunges 54% as late 10-Q, SEC requests and CFO exit hit confidence
Next Story

Kyndryl stock plunges 54% as late 10-Q, SEC requests and CFO exit hit confidence

Go toTop